Everett Harris & Co’s Zimmer Biomet ZBH Stock Holding History

Everett Harris & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.55M	Sell	29,647 -31,323	-51%	-$2.75M	0.03%	104
2026 Q1	$5.51M	Buy	60,970 +28,920	+90%	+$2.65M	0.07%	77
2025 Q4	$2.88M	Sell	32,050 -450	-1%	-$42.7K	0.03%	97
2025 Q3	$3.2M	Sell	32,500 -1,175	-3%	-$116K	0.04%	89
2025 Q2	$3.07M	Sell	33,675 -279	-0.8%	-$27K	0.04%	91
2025 Q1	$3.84M	Sell	33,954 -806	-2%	-$86.2K	0.05%	85
2024 Q4	$3.67M	Sell	34,760 -3,337	-9%	-$358K	0.05%	84
2024 Q3	$4.11M	Sell	38,097 -1,130	-3%	-$123K	0.05%	79
2024 Q2	$4.26M	Sell	39,227 -3,275	-8%	-$386K	0.05%	75
2024 Q1	$5.61M	Sell	42,502 -1,656	-4%	-$207K	0.07%	69
2023 Q4	$5.37M	Sell	44,158 -1,015	-2%	-$113K	0.08%	64
2023 Q3	$5.07M	Sell	45,173 -2,438	-5%	-$310K	0.08%	64
2023 Q2	$6.93M	Sell	47,611 -7,865	-14%	-$1.07M	0.11%	58
2023 Q1	$7.17M	Sell	55,476 -4,145	-7%	-$520K	0.12%	60
2022 Q4	$7.6M	Sell	59,621 -2,330	-4%	-$270K	0.13%	58
2022 Q3	$6.48M	Sell	61,951 -2,655	-4%	-$291K	0.12%	59
2022 Q2	$6.79M	Sell	64,606 -4,365	-6%	-$518K	0.12%	63
2022 Q1	$8.82M	Sell	68,971 -2,661	-4%	-$321K	0.13%	60
2021 Q4	$8.84M	Sell	71,632 -2,096	-3%	-$274K	0.12%	62
2021 Q3	$10.5M	Buy	73,728 +1,255	+2%	+$185K	0.17%	51
2021 Q2	$11.3M	Sell	72,473 -169	-0.2%	-$27.4K	0.18%	51
2021 Q1	$11.3M	Sell	72,642 -1,375	-2%	-$213K	0.2%	51
2020 Q4	$11.1M	Sell	74,017 -1,081	-1%	-$153K	0.2%	50
2020 Q3	$9.93M	Sell	75,098 -2,691	-3%	-$352K	0.19%	52
2020 Q2	$9.01M	Sell	77,789 -2,426	-3%	-$280K	0.2%	50
2020 Q1	$7.87M	Buy	80,215 +968	+1%	+$127K	0.2%	50
2019 Q4	$11.5M	Sell	79,247 -582	-0.7%	-$80.3K	0.26%	47
2019 Q3	$10.6M	Sell	79,829 -6,522	-8%	-$842K	0.26%	48
2019 Q2	$9.87M	Sell	86,351 -2,760	-3%	-$323K	0.25%	47
2019 Q1	$11M	Sell	89,111 -3,332	-4%	-$379K	0.29%	44
2018 Q4	$9.31M	Sell	92,443 -13,062	-12%	-$1.47M	0.26%	45
2018 Q3	$13.5M	Sell	105,505 -10,156	-9%	-$1.21M	0.34%	42
2018 Q2	$12.5M	Sell	115,661 -9,917	-8%	-$1.08M	0.34%	42
2018 Q1	$13.3M	Buy	125,578 +827	+0.7%	+$96K	0.37%	41
2017 Q4	$14.6M	Sell	124,751 -164,070	-57%	-$18.6M	0.41%	41
2017 Q3	$32.8M	Buy	288,821 +3,054	+1%	+$353K	0.99%	29
2017 Q2	$35.6M	Buy	285,767 +16,560	+6%	+$1.96M	1.1%	25
2017 Q1	$31.9M	Buy	269,207 +24,200	+10%	+$2.74M	1.04%	26
2016 Q4	$24.5M	Buy	245,007 +95,687	+64%	+$10.3M	0.86%	32
2016 Q3	$18.8M	Buy	149,320 +36,339	+32%	+$4.49M	0.67%	36
2016 Q2	$13.2M	Sell	112,981 -1,802	-2%	-$204K	0.47%	42
2016 Q1	$11.9M	Sell	114,783 -3,631	-3%	-$351K	0.43%	42
2015 Q4	$11.8M	Sell	118,414 -1,931	-2%	-$189K	0.41%	43
2015 Q3	$11M	Buy	120,345 +7,447	+7%	+$747K	0.4%	44
2015 Q2	$12M	Sell	112,898 -464	-0.4%	-$51.3K	0.42%	41
2015 Q1	$12.9M	Sell	113,362 -309	-0.3%	-$35.3K	0.44%	41
2014 Q4	$12.5M	Sell	113,671 -9,001	-7%	-$949K	0.43%	42
2014 Q3	$12M	Sell	122,672 -4,074	-3%	-$401K	0.43%	43
2014 Q2	$12.8M	Sell	126,746 -5,867	-4%	-$572K	0.47%	43
2014 Q1	$12.2M	Sell	132,613 -3,922	-3%	-$361K	0.45%	44
2013 Q4	$12.4M	Sell	136,535 -700	-0.5%	-$60.6K	0.46%	42
2013 Q3	$10.9M	Sell	137,235 -4,430	-3%	-$349K	0.45%	45
2013 Q2	$10.3M	Buy	+141,665	New	+$10.6M	0.43%	44

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Everett Harris & Co's ZBH Position: Q2 2026 in Review

Everett Harris & Co reduced its Zimmer Biomet (ZBH) stake by 51% in Q2 2026, selling an estimated $2.75M and leaving 29,647 shares worth $2.55M. The position accounts for 0.03% of the portfolio, ranked #104.

Everett Harris & Co first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.6M in Q2 2017. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Everett Harris & Co held 29,647 shares of Zimmer Biomet worth $2.55M as of Q2 2026.
Everett Harris & Co sold 31,323 Zimmer Biomet shares in Q2 2026, an estimated $2.75M.
Zimmer Biomet made up 0.03% of Everett Harris & Co's portfolio in Q2 2026, its #104 holding.
Everett Harris & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
Everett Harris & Co's Zimmer Biomet position peaked at $35.6M in Q2 2017.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.